EP 17 - Asthma Care in 2025: Innovations, Biologics, and Personalized Treatments episode artwork

EPISODE · Oct 30, 2025 · 20 MIN

EP 17 - Asthma Care in 2025: Innovations, Biologics, and Personalized Treatments

from Passion for Patients · host Tonya

Welcome to another episode of the Passion for Patients podcast, hosted by Tonya Winders, President and CEO of GAAP. In this episode, Tonya is joined by Dr. Karen Rance, GAAP’s Chief Medical Officer, to dive into the latest scientific updates on asthma care for 2025 and beyond. Together, they explore the cutting-edge advances shaping asthma management, including personalized treatments, the evolving role of biologics, and the integration of smart technologies like wearables and smart inhalers. They also discuss shifting global guidelines, address the impact of environmental and regional triggers, and highlight the importance of self-management, symptom tracking, and equitable access to care. Whether you’re a patient, caregiver, or healthcare professional, this episode provides practical tips and forward-looking insights to help you live well with asthma today—and tomorrow. Tune in for an engaging conversation packed with expert advice and the latest updates you need to know!Here are the top 3 takeaways for anyone in healthcare, advocacy, or living with asthma:🔹 Personalized & Precise Treatments:We’re moving beyond “one size fits all.” New guidelines are focused on personalized care—identifying treatable traits (like allergies, obesity, and environmental triggers) and matching treatments accordingly. Understanding your personal asthma triggers and working closely with your healthcare team is more important than ever.🔹 Tech-Enabled Self-Management:From smart inhalers and wearable technology to journaling symptoms, there’s a major push toward empowering patients through technology and self-awareness. Smart (Single Maintenance and Reliever Therapy) approaches are gaining traction for better adherence and outcomes.🔹 Equity & Access Matter:Access to essential medicines like inhaled corticosteroids and advanced biologics remains a challenge in many regions. Organizations like GAAP are deeply invested in ensuring equitable access to treatments worldwide—because everyone deserves the chance to live well with asthma.Let’s keep advocating for innovation, access, and empowerment in respiratory health!If you’re interested in the full conversation, catch the Passion for Patients podcast and stay tuned for more scientific updates..#AsthmaCare #PatientEmpowerment #HealthcareInnovation #PassionForPatients #RespiratoryHealth#PatientAdvocacy #HealthcareInnovation #PassionForPatients

Episode metadata supplied by the publisher feed · Published Oct 30, 2025

Embed this episode

NOW PLAYING

EP 17 - Asthma Care in 2025: Innovations, Biologics, and Personalized Treatments

0:00 20:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Passion for Patients?

This episode is 20 minutes long.

When was this Passion for Patients episode published?

This episode was published on October 30, 2025.

Can I download this Passion for Patients episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!